Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Shanghai Kehua Bio-Engineering Co Ltd (002022)

Shenzhen
Currency in CNY
Disclaimer
7.95
-0.05(-0.63%)
Delayed Data
High dividend Yield
Fair Value
Unlock Value
Day's Range
7.888.05
52 wk Range
6.1914.30
Bid/Ask
7.94 / 7.95
Prev. Close
8
Open
8.62
Day's Range
7.88-8.05
52 wk Range
6.19-14.3
Volume
2,649,800
Average Vol. (3m)
9,298,673
1-Year Change
-35.24%
Shares Outstanding
514,302,062
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
13.00
Upside +63.52%
How do you feel today about 002022?
Vote to see community's results!
or

Shanghai Kehua Bio-Engineering Co Ltd Company Profile

Shanghai Kehua Bio-Engineering Co.,Ltd researches and develops, produces, and sells in vitro diagnostic reagents and automatic analyzers in China. It offers signature products, including immunoassay & clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management, and automated comprehensive solutions for nucleic acid blood screening; and immunologic diagnosis products, such as KHB Polaris i1800 full-automatic chemiluminescence immunoassay analysis systems, Polaris i2400 fully automated chemiluminescence immunoassay analysis systems, enzyme linked immunosorbent assay kits, and microplate reader and plate washers. The company also provides biochemical diagnosis products, including ZY Series of automatic clinical chemistry analyzers, Polaris c1000 fully automated modular clinical chemistry analysis systems, and general packaging reagents; and molecular diagnostics products, such as nucleic acid extractors, PCR thermal cyclers, real-time PCR systems, automatic nucleic acid workstations, and compatible kits for extraction and detection; and KHB molecular diagnostics reagents, as well as KHB anti-HIV colloid gold products. It serves hospitals, disease control and prevention centers, blood centers, bio-pharmaceutical enterprises, and scientific research institutions. The company also exports its products. Shanghai Kehua Bio-Engineering Co.,Ltd was founded in 1981 and is headquartered in Shanghai, the People's Republic of China.

Employees
2709
Market
China
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.